Cancer is a genetic disease, caused by specific changes to the genes controlling the way cells function, particularly how they grow and divide. Genes are functional units of heredity made … Continue Reading Ancient DNA could identify and kill cancer.
Widely hailed as a breakthrough in cancer therapy, immunotherapies release the brakes of the body’s immune system to launch an efficient tumor attack, however, these treatments don’t work for every … Continue Reading Gut microbiome directs immune system to fight cancer.
Melanoma is one of the types of cancer that poses the greatest challenge to researchers because it manifests itself in many ways, it contains a large number of mutations and … Continue Reading Researchers identify a new molecular biomarker for malignant melanoma.
Natural killer (NK) cells are bone marrow–derived granular lymphocytes that have a key role in immune defense against viral and bacterial infections and malignancies. NK cells are traditionally defined as … Continue Reading Study shows that natural killer cells have a memory.
Melanoma is the deadliest skin cancer whose rates have doubled over the last three decades, killing approximately 10,130 people annually. More than 90% of melanoma skin cancers develop because of … Continue Reading Researchers identify ‘sunscreen gene’ that suppresses skin cancer.
Being able to detect early on whether a cancer therapy is working proffers obvious benefits for therapy-outcomes whilst influencing the course of treatment and improving the quality of life for … Continue Reading Novel ‘reporter’ nanoparticle reveals cancer treatment effectiveness in real-time.
It is known that cancer cells don’t live on glass slides, yet the vast majority of images related to cancer biology come from the cells being photographed on flat, two-dimensional … Continue Reading New 3D- imaging provides unprecedented views of cancer in it’s natural environment.
An important mystery has been why some cells in the body already have mutations seen in cancer, yet do not fully behave like the cancer. Now, researchers led by the … Continue Reading In a world’s first, researchers image the origins of cancer from the first affected cell.
Melanoma incidence has been rapidly increasing worldwide, with fewer than 10% of people whose melanoma tumours have spread or metastasized surviving longer than a decade after detection. Despite the considerable … Continue Reading New ctDNA blood-test for melanoma beats standardised test in human trials.
There is well-established evidence that free radicals can cause cancer so researchers had assumed that antioxidants, which destroy them, provide protection against the disease. Found in many nutritional supplements, antioxidants … Continue Reading Study shows antioxidants speed-up the metastasis of malignant melanoma.
Skin cancer is the most common of all cancers, and melanoma, which accounts for 2% of skin cancer cases, is responsible for nearly all skin cancer deaths. Melanoma rates in … Continue Reading Researchers identify the precise trigger of melanoma.
A new collaborative study led by researchers at Sanford-Burnham Medical Research Institute provides new insight into the molecular changes that lead to resistance to a commonly prescribed group of drugs … Continue Reading Researchers identify new epigenetic pathway in drug-resistant melanoma.
A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of … Continue Reading New treatment blocks progression of mutliple sclerosis in animal model.
Seeking a way to stimulate antitumour responses via the immune system researchers from the Norris Cotton Cancer Center at Dartmouth have identified the precise temperature that results in a distinct … Continue Reading Researchers use nanoparticles at specific temperature to stimulate antitumour response.
In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers at NYU Langone Medical Center have identified two tiny bits of … Continue Reading Largest ever analysis maps epigenetic methylation pathway which suppresses the spread of melanoma.
A team of researchers led by Duke Cancer Institute have identified key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies. By mapping the points of … Continue Reading Researchers begin to map epigenetic methylation in specific cancer drug resistance.